top of page
pexels-jopwell-2422293.jpg
September 16, 12pm ET | JH AITC Webinar

"Overlooked and at Risk: Confronting the Rise of Substance Use in Older Adults Though Interdisciplinary Innovation"

Bethea AnnaLouise Kleykamp, PhD

Johns Hopkins University


The JH AITC is a national resource funded to promote the development and implementation of novel artificial intelligence (AI) and technology approaches to improve the health and well-being of older adults. The purpose of this webinar series is to facilitate conversations between engineers, clinicians, industry, government, academia, and stakeholder groups to advance science and build transdisciplinary collaborations.



September 23, 4pm ET | MassAITC Webinar

"Intelligent Mobile Systems for an Aging Population"

Justin Chan, PhD

Carnegie Mellon University


By 2050, older adults will make up about 22% of the global population, driving an urgent need for accessible and reliable health technologies. This talk, will present work on intelligent mobile systems designed for older adults. The first enables low-cost health screening using everyday earphones and wireless earbuds. The second is an ambient sensing system that uses smart devices to detect emergent, life-threatening events such as cardiac arrest. The third leverages compact AI-enabled radios for cardiovascular monitoring, including blood pressure. Through these examples, Dr. Chan will show how computational and sensing techniques that generalize across hardware and operate in real-world environments can address pressing societal challenges.



October 16, 4-5pm ET | Clin-STAR Webinar

"The Art and Science of the Pilot Study: Challenges and Solutions"

Kenneth Schmader, MD

with Carl F. Pieper, DrPH

Duke University School of Medicine


Webinar Objectives:

  • To describe challenges and solutions in the design of a pilot study protocol

  • To describe challenges and solutions in the conduct of a pilot study

  • To list publication and funding opportunities for pilot studies



October 1, 3-4pm ET | AGING Initiative-GEAR Collaborative Webinar

"Do Multiple Chronic Conditions Matter in the ED?"

Justine Seidenfeld, MD, MHS Durham VA Health Care System Duke University School of Medicine

Jane Jih, MD, MPH, MAS University of California San Francisco


Patients experiencing a medical emergency require rapid identification of the main problem, accurate diagnosis, and timely treatment. Providing this care in the fast-paced environment of the emergency department (ED) is challenging when older adults present with multiple chronic conditions (MCCs). Please join Drs. Seidenfeld and Jih to discuss why MCCs matter in the ED.



October 9-12 | Masoro-Barshop Conference on Aging

"Dietary Approaches to Geroscience Intervention"

The Mayan Dude Ranch, Bandera, Texas


The Masoro-Barshop Conference on Aging is held each year in Bandera, TX, to assemble leaders in a thematic area of geroscience in an informal setting to maximize discussion on their recent research discoveries. This format provides opportunities for investigators and trainees to learn about this cutting-edge research and interact with leaders in the field. Held annually at the Mayan Dude Ranch in Bandera TX, this conference highlights rotating thematic areas of geroscience, since the process of aging is a complex biological phenomenon encompassing and affecting numerous changes at the cellular and physiological level. The conference is supported by the aging research programs associated with the Sam and Ann Barshop Institute for Longevity and Aging Studies.


Speakers:

Rozalyn Anderson, PhD

University of Wisconsin-Madison

Doug Mashek, PhD

University of Minnesota

Tracy G. Anthony, PhD

Rutgers University

Debora Melo van Lent, PhD

UT Health San Antonio

Sebastian Brandhorst, PhD

University of Southern California

Benjamin Miller, PhD

Oklahoma Medical Research Foundation

Yan Du, PhD, MPH, RN

UT Health San Antonio

James F. Nelson, PhD

UT Health San Antonio

Luigi Ferrucci, MD, PhD

National Institute on Aging

Satchidananda Panda, PhD

Salk Institute for Biological Studies

David Gius, MD, PhD

UT Health San Antonio

Courtney Peterson, PhD, MSc, MA, MS

Harvard T.H. Chan School of Public Health

Cristal M. Hill, PhD

University of Southern California

Corinna Ross, PhD

Texas BioMedical Research Institute

Catherine Kaczorowski, PhD

University of Michigan

Elena Volpi, MD, PhD, FGSA

UT Health San Antonio

Pankaj Kapahi, PhD

Buck Institute for Research on Aging

Shangang Zhao, PhD

UT Health San Antonio

Dudley Lamming, PhD

University of Wisconsin-Madison


November 11, 9-1pm | NIA Geroscience Education and Training (GET) Network: Progress Report and Update

This NIA Geroscience Education and Training (GET) Network (R25AG073119) half day workshop will introduce attendees to GET Network Geroscience education curricula and resources and provide an update on recent milestones and progress in creating training materials. Attendees will learn about available materials that they can use for educating aspiring translational geroscientists in their training programs, or for introducing graduate students, medical students or geriatrics fellows to geroscience. The workshop will describe the route to obtaining the GET Network’s Certificate Program in Translational Geroscience at currently participating institutions and introduce the GET2 Network, a collaboration with the Gerontological Society of America to make materials available to all interested institutions for use in their geroscience education efforts. The GET Network will solicit feedback and input from workshop attendees on resources presented through discussions and Q&A sessions.




A Three-Part Webinar Series Aimed at Identifying and Prioritizing Intervention Research Topics Linked to Care Recipient Placement in Assisted Living Settings and the Challenges of Maintaining a Continued Caregiving Role


Webinar Series Overview
  •  Designed for researchers engaged with family caregivers of persons living with dementia

  • Discussion will focus on the challenges family caregivers have faced placing a care recipient

  • in an assisted living community

  • Learn from a panel of family caregivers of assisted living residents with dementia from across the country, as well as insights from several studies focused on this topic

Tuesday, September 16th

2:00p-3:30p Eastern Time

  • Design Principles presentation

  • Caregivers share challenges/problems

Tuesday, September 23rd

2:00p-3:30p Eastern Time

  • What caregivers wished they knew

Tuesday, September 30th

2:00p-3:30p Eastern Time

  • Presentation & insight from studies of caregiving in assisted living settings



Science-backed gerotherapeutics can target the biological mechanisms of aging in order to extend health and prevent and delay diseases and conditions common to our bodies as we grow older. Bolstered by discoveries at academic labs and emerging biotech companies, these innovations are poised to move from bench to bedside.


And from The New York Times to WIRED, the BBC to Netflix, National Geographic to JAMA and beyond, the promise of these age-targeting therapeutic interventions — such as Metformin, Rapamycin, and even GLP-1s — continues to generate media attention and tantalize consumers. At the same time, an explosion of “anti-aging” supplements and claims of biohacking “remedies” from questionable sources is muddying the waters.


Amid this buzz, how do we distinguish the hype from the hope and the science from the spin?

To provide a reality check on the readiness and intentions of gerotherapeutics, AFAR and the Academy for Health and Lifespan Research (AHLR) invite you to a free webinar on the current state of existing and emerging drug interventions to extend healthspan, our years of health as we grow older.


Renowned leaders from the academic, clinical, and private sectors will:

  • Clarify how both repurposing existing drugs and developing novel compounds can extend healthspan

  • Unpack the need for human trials, the importance of an FDA indication for aging, as well as the risks in off-label use and harm of radical life extension claims

  • Counter myths and misinformation with accurate expectations and language

  • Confront barriers that impact gerotherapeutics from safely entering the market

  • Explore how drug and lifestyle interventions work together to help us live healthier, longer at any age


The expert-backed conversation also will touch on hot topics such as the federal path to drug discovery, the momentum of the private biotech sector, the emerging use of GLP1s and SGL2s to extend healthspan, and what’s needed next to bring these promising therapeutics to consumers and clinicians soon.


Please join for an expert-led conversation on the promise of therapeutics to help us all live healthier, longer!


bottom of page